Home
/
NRX Pharmaceuticals, Inc.
/
Financials
/
Quarterly
NRX Pharmaceuticals, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that NRX Pharmaceuticals, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2025
$242.0K
Nov 14, 2025
Q2
2024
Jun 30, 2025
$0
Aug 18, 2025
Q1
2024
Mar 31, 2025
$0
May 15, 2025
Q3
2024
Sep 30, 2024
$0
Nov 14, 2025
Q2
2024
Jun 30, 2024
$0
Aug 14, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2025
($5.89M)
Nov 14, 2025
Q3
2024
Jun 30, 2025
($17.58M)
Nov 14, 2025
Q2
2024
Jun 30, 2025
($17.58M)
Aug 18, 2025
Q3
2024
Mar 31, 2025
($5.51M)
Nov 14, 2025
Q2
2024
Mar 31, 2025
($5.51M)
Aug 18, 2025
Q1
2024
Mar 31, 2025
($5.51M)
May 15, 2025
Q3
2024
Sep 30, 2024
($1.62M)
Nov 14, 2025
Q3
2024
Jun 30, 2024
($7.90M)
Nov 14, 2025
Q2
2024
Jun 30, 2024
($7.90M)
Aug 18, 2025
Q2
2024
Mar 31, 2024
($6.53M)
Aug 18, 2025
Q3
2024
Mar 31, 2024
($6.53M)
Nov 14, 2025
Q1
2024
Mar 31, 2024
($6.53M)
May 15, 2025
Q3
2024
Sep 30, 2023
($6.06M)
Nov 14, 2024
Q3
2024
Jun 30, 2023
($8.72M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($8.72M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($5.51M)
May 15, 2025
Q3
2024
Mar 31, 2023
($11.04M)
Nov 14, 2024
Q2
2024
Mar 31, 2023
($11.04M)
Aug 14, 2024
Q3
2023
Sep 30, 2022
($9.08M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($6.98M)
Aug 14, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2025
($4.02M)
Nov 14, 2025
Q2
2024
Jun 30, 2025
($3.73M)
Aug 18, 2025
Q3
2024
Sep 30, 2024
($3.02M)
Nov 14, 2025
Q2
2024
Jun 30, 2024
($7.05M)
Aug 18, 2025
Q1
2024
Mar 31, 2024
($6.00M)
May 15, 2025
Q3
2024
Sep 30, 2023
($5.81M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($8.19M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($3.85M)
May 15, 2025
Q3
2023
Sep 30, 2022
($9.14M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($9.60M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($15.71M)
May 15, 2023
Q3
2022
Sep 30, 2021
($20.10M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($17.12M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($25.61M)
May 16, 2022
Q3
2021
Sep 30, 2020
($5.15M)
Aug 12, 2022
Q2
2021
Jun 30, 2020
$104.8K
Aug 12, 2022
Q1
2021
Mar 31, 2020
($119.3K)
May 21, 2021
Q3
2020
Sep 30, 2019
($183.3K)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($175.7K)
Aug 14, 2020
Q1
2020
Mar 31, 2019
($163.2K)
May 15, 2020